-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Paulina Ibarra
2011 BIO International Convention Preview
Andrew Williams, from Patent Docs wrote a nice blog on the upcoming 2011 BIO International Convention. Therefore, over the next week, Patent Docs will be highlighting a few sessions or other opportunities, in thematic fashion, to help you navigate your way through the convention. For example, today we present opportunities for those intested in learning more about how the Supreme Court is impacting the BIO community. Take a look at his entry, and keep an Read More >
2011 BIO International event spotlights expert feedback on regulatory strategy
Our good friend John Carroll, blogs on the free ranging discussion he will be hosting during the 2011 BIO International Convention, and tackling one of the most complex issues of the day for biopharma companies. You can send your questions to the panel of experts discussing the issues. In the meantime, you can also email John if there are any regulatory issues you are interested on discussing.
Scientific American Worldview 2011 Preview – Three pioneers share keys to success for building biotech in emerging markets
Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India. This year’s report will profile: Guilherme Emrich, FIR Capital (Brazil) Ge Li, WuXi Apptec (China) Kiran Mazumdar-Shaw, Biocon (India) Their opinions and advice on a diverse range of subjects is explored in a Q&A while their individual stories are told in accompanying profiles. Don’t miss this special section in the Read More >
The Latest in Advanced Biofuels and Climate Change
“Four more BIO interviews remaining in the pipeline (woohooo!). This one is my interview with Dennis McGrew, Genomatica’s new executive vice president of business development and chief business officer.” So begins the post by Doris de Guzman of ICIS Green Chemicals . Guzman interviewed Dennis McGrew, Genomatica’s new executive vice president of business development and chief business officer. “Genomatica,” Guzman writes, announced at the BIO industrial biotech conference that it was able to achieved pilot-scale Read More >
Jerry Pommer: Livestock Biotech Conference Preview
BIOtech Now visited with Jerry Pommer, Director of Animal Regulatory Compliance and Quality Assurance for Hematech, Inc. in Sioux Falls, South Dakota. Jerry is a member of the program steering committee for BIO’s first-ever Livestock Biotech Summit, which will provide participants with three days of cross-cutting discussions among industry, academic and government leaders on the care and use of animals in research and the many possibilities in the realm of GE animal research, regulation, and Read More >
